{"transactions":[{"id":4638367,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-09T01:58:49.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13871,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821432/000119312526418323/ownership.xml","form_type":"4"}},{"id":880790,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T22:55:54.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":8170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026."}],"balance_after":13871,"source":{"system":"sec-edgar","filing":"0001628280-26-012477","document":"wk-form4_1772146552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012477/wk-form4_1772146552.xml","form_type":"4"}},{"id":1196282,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-20T23:09:27.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":5701,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the \"2023 Plan\") and fully vests on the first anniversary of the measurement date of 01-02-2025."}],"balance_after":5701,"source":{"system":"sec-edgar","filing":"0001628280-25-014191","document":"wk-form4_1742512161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025014191/wk-form4_1742512161.xml","form_type":"4"}},{"id":1330231,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-12-18T00:30:05.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0.31,"value":26350.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":128790,"source":{"system":"sec-edgar","filing":"0001493152-24-050500","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/73290/000149315224050500/ownership.xml","form_type":"4"}},{"id":1711875,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option","published_at":"2023-12-14T22:10:34.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options granted to Ms. Coste as part of her Fiscal 2024 Board compensation package."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable"}],"balance_after":75000,"derivative":{"exercise_price":1.01,"exercise_date":"2024-12-13","expiration_date":"2034-12-13","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-23-044907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000149315223044907/ownership.xml","form_type":"4"}},{"id":1717254,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option","published_at":"2023-12-11T22:18:40.000Z","date":"2023-04-20","kind":"grant","planned":false,"acquired":true,"shares":32000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options granted to Ms. Coste in April 2023 as part of her fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable"}],"balance_after":32000,"derivative":{"exercise_price":1.67,"exercise_date":"2023-12-07","expiration_date":"2033-04-20","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001493152-23-044430","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000149315223044430/ownership.xml","form_type":"4"}},{"id":1731398,"issuer":{"id":7446,"kind":"organization","name":"Renalytix plc"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-22T21:29:33.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is 0.245 pounds sterling. The U.S. dollar equivalent of the exercise price is $0.304 using the Bank of England rate as of November 17, 2023 (1.00 pound sterling = $1.243)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One twelfth (1/12th) of the shares subject to the option award shall vest in equal quarterly installments commencing on February 20, 2024, subject to the Reporting Person's continuous service."}],"balance_after":95000,"derivative":{"exercise_price":0.304,"expiration_date":"2033-11-19","underlying":"Ordinary Shares","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-23-056478","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811115/000120919123056478/doc4.xml","form_type":"4"}},{"id":1832996,"issuer":{"id":7446,"kind":"organization","name":"Renalytix plc"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-07T20:28:15.000Z","date":"2023-07-06","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is 1.025 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.301 using the Bank of England rate as of July 6, 2023 (1.00 pound sterling = $1.269)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third (1/3rd) of the shares subject to the option award shall vest on July 6, 2024, and one eighth (1/8th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":190000,"derivative":{"expiration_date":"2033-07-05","underlying":"Ordinary Shares","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001209191-23-041800","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811115/000120919123041800/doc4.xml","form_type":"4"}},{"id":2043148,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Audit Committee Chairperson"}}],"security":"Common Stock","published_at":"2023-01-30T16:36:42.000Z","date":"2023-01-26","kind":"purchase","acquired":true,"shares":2190,"price":2.96,"value":6482.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open Market Purchase"}],"balance_after":43790,"source":{"system":"sec-edgar","filing":"0001513162-23-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316223000010/primary_doc.xml","form_type":"4"}},{"id":2232553,"issuer":{"id":115564,"kind":"organization","name":"MINERVA SURGICAL INC","symbol":"UTRS"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T13:05:15.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":49792,"price":2.41,"value":119998.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. Each RSU award will vest in four equal quarterly installments on the quarterly anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. Each RSU award will vest in four equal quarterly installments on the quarterly anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"79,787 shares were acquired pursuant to the exercise of an early-exercise option and remain subject to a right of repurchase by the Company, which shall lapse with respect to one-fourth of the shares on February 1, 2022 and with respect to one thirty-sixth of the remaining shares each month thereafter."}],"balance_after":129579,"source":{"system":"sec-edgar","filing":"0001209191-22-036604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1452965/000120919122036604/doc4.xml","form_type":"4"}},{"id":2478323,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option","published_at":"2021-12-10T22:18:24.000Z","date":"2021-12-09","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable"}],"balance_after":70000,"derivative":{"exercise_price":4.46,"exercise_date":"2022-12-09","expiration_date":"2031-12-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001513162-21-000145","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316221000145/primary_doc.xml","form_type":"4"}},{"id":2949524,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option","published_at":"2020-12-12T00:57:13.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable"}],"balance_after":45000,"derivative":{"exercise_price":6.36,"exercise_date":"2021-12-10","expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001513162-20-000238","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316220000238/primary_doc.xml","form_type":"4"}},{"id":2999766,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-27T22:34:49.000Z","date":"2020-10-26","kind":"purchase","acquired":true,"shares":9100,"price":5.45,"value":49595.0,"ownership":{"direct":false,"nature":"See Note 1."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares were purchased through spouse's retirement account."}],"balance_after":9100,"source":{"system":"sec-edgar","filing":"0001513162-20-000217","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316220000217/primary_doc.xml","form_type":"4"}}]}